Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Teva
Express Scripts
Deloitte
McKinsey
Dow
Julphar
Merck
Accenture

Generated: August 20, 2018

DrugPatentWatch Database Preview

COLESTID Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Colestid patents expire, and when can generic versions of Colestid launch?

Colestid is a drug marketed by Pharmacia Upjohn and is included in two NDAs.

The generic ingredient in COLESTID is colestipol hydrochloride. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the colestipol hydrochloride profile page.

Drug patent expirations by year for COLESTID
Pharmacology for COLESTID
Medical Subject Heading (MeSH) Categories for COLESTID
Synonyms for COLESTID
37296-80-3
AC1MJ2ZS
C11H28ClN5O.HCl
C60H114O8.HCl
Cholestabyl
Colestipol HCl
Colestipol hydrochloride
Colestipol hydrochloride [USAN:USP]
Colestipol hydrochloride [USAN]
Copolymer of diethylenetriamine and 1-chloro-2,3-epoxypropane, hydrochloride (with approximately 1 out of 5 amine nitrogens protonated)
D0GJ8R
DTXSID40190737
Flavored Colestid
FT-0749664
GACQNVJDWUAPFY-UHFFFAOYSA-N
Lestid
LS-54700
N'-[2-[2-(2-aminoethylamino)ethylamino]ethyl]ethane-1,2-diamine hydrochloride
SCHEMBL284758
tetraethylenepentamine HCl
U-26597A
UNII-X7D10K905G
X7D10K905G

US Patents and Regulatory Information for COLESTID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia Upjohn COLESTID colestipol hydrochloride GRANULE;ORAL 017563-003 Sep 22, 1995 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia Upjohn COLESTID colestipol hydrochloride GRANULE;ORAL 017563-004 Sep 22, 1995 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia Upjohn COLESTID colestipol hydrochloride TABLET;ORAL 020222-001 Jul 19, 1994 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Paragraph IV (Patent) Challenges for COLESTID
Drugname Dosage Strength RLD Date
➤ Subscribe Tablets 1 g ➤ Subscribe ➤ Sign Up

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Baxter
Queensland Health
QuintilesIMS
McKesson
UBS
Medtronic
Cerilliant
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.